Clinical Trial Update: Absorption and Pharmacokinetics of Nitroglycerin to a New Formulation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining absorption and pharmacokinetics of a new nitroglycerin formulation for angina pectoris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: Kolding Sygehus | Conditions: Angina Pectoris | Phase 4 | Status: UNKNOWN